業績

2016年 研究・実績

英論文

  1. Booka E,Imamura C,Takeuthi H,Hamamoto Y,Gomi D,Mizukami T,Ichiyama T,Tateisi K,Takahasi T,Kawakubo H,Soejima K,Boku N,Tanigawara Y,Kitagawa Y:Development of an S-1 dosaga formula based on renal function by prospective pharmacokinetic study. Gastric Cancer 19:876–886,2016.
  2. Sano T,Uhara H,Mikoshiba Y,Kobayashi A,Uchiyama R,Tateishi K,and Yamamoto H,Okuyama R:Nivolumab-induced organizing pneumonia in a melanoma patient.japanese journal of Clinical Oncology 1-3,2016.
  3. Matsui S,Yamamoto H,Minamoto S,Waseda Y,Mishima M,Kubo K:Proposed diagnostic criteria for IgG4-related respiratory disease. Respiratory Investigation 54:130-132,2016.
  4. Masaki Y,Kawabata H,Takai K,Kojima M,Tsukamoto N,Ishigaki Y,Kurose N,Ide M,Murakami J,Nara K,Yamamoto H,Ozawa Y,Takahashi H,Miura K,Miyauchi T,Yoshida S,Momoi A,Awano N,Ikushima S,Ohta Y,Furuta N,Fujimoto S,Kawanomi H,Sakai T,Kawanami T,Fujita Y,Fukushima T,Nakamura S,Kinoshita T,Aoki S:Proposed diagnostic criteria,disease severity classification and treatment strategy for TAFRO syndrome,2015 version.Int J Hematol 103:686–692,2016.
  5. Kitaguchi Y,Yasuo M,Hanaoka M:Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome,and asthma with airflow limitation.International Journal of COPD 11:991-997,2016.
  6. Hayashida M,Yasuo M,Hanaoka M,Seyama K,Inoue Y,Tatsumi K,Mishima M:Reductions in pulmonary function detected in patients with lymphangioleomyomatosis:Ananalysis of the Japanese National Research Project on Intractable Diseases database.Respiratory Investigation 54: 193-200,2016.
  7. Hama M,Ushiki A,Kosaka M,Yamazaki Y,Yasuo M,Yamamoto H,Hanaoka M.Health-related quality of life in patients with pulmonary non-tuberculous mycobacteria infection.INT J TUBERC LUNG DIS20(6):747-752 ,2016.
  8. Yasuo M,Kobayashi T,Hama M,Ichiyama T,Horiuchi T,Yamamoto H,Kawakami S,Hamanoka K,Honda T,Hanaoka M:Combination of virtual bronchoscopic navigation with conventional transbronchial needle aspiration in the diagnosis of peribronchial pulmonary lesions located in the middle third of the lungs.Respiratory investigation 54:335-363,2016.
  9. Tokoro Y,Yasuo M,Kobayashi T,Hama M,Ichiyama T,Horiuchi T,Ushiki A,Kawakami S,Honda T,Hanaoka M:Computed tomography-guided bronchoscopy in the diagnosis of small peripheral pulmonary lesions:A retrospective study of 240 examinations in a single academic center.Respiratory Investigation.54(5):347-354,2016.
  10. Kato A, Yamamoto H, Ikeda M, Tateishi K, Ushiki A, Yasuo M, Kawakami S, Asaka S , Oguchi K, Hanaoka M:A case of pulmonary Mycobacterium avium infection in an immunocompetent patient who showed a huge consolidation with a high FDG uptake on PET/CT.Respiratory Medicine Case Reports 19:49-52,2016.
  11. Yamauchi H,Bando M,Baba T,Kataoka K,Yamada Y,Yamamoto H,Miyamoto A, Ikushima S,Johkoh S,Sakai F,Terasaki Y,Hebisawa A,Kawabata Y,Sugiyama Y,Ogura T:Clinical Course and Changes in High-Resolution Computed Tomography Findings in Patients with Idiopathic PulmonaryFibrosis without Honeycombing.PLOS ONE 11(11)| DOI:10.1371/November 9,2016.
  12. Zhang M, Yoshizawa A, Kawakami S, Asaka S, Yamamoto H,Yasuo M, Agatsuma H, Toishi M, Shiina T, Yoshida K,Honda T& Ito K,:The histological characteristics and clinical outcomes of lung cancer in patients with combined pulmonary fibrosis and emphysema.Cancer Medicine 5(10):2721–2730,2016.
  13. Yasuo M:Combination of virtual bronchoscopic navigation with conventional transbronchial needle aspiration in the diagnosis of peribronchial pulmonary lesions located in the middle third of the lungs.Respiratory Investigation.54(6):Issue Highlights, 2016.
  14. Ozawa Y, Yamamoto H, Yasuo M, Takahashi H, Kazunari Tateishi K, Ushiki A, Kawakami S, Fujinaga Y, Asaka S, Sano K,Takayama H, Imamura H, Hanaoka M:Two patients with TAFRO syndrome exhibiting strikingly similar anterior mediastinal lesions with predominantly fat attenuation on chest computed tomography. Respiratory Investigation. 54(6):Articles in Press,2016.
  15. WadaY, Koyama S, Kuraishi H, Miyahara T,Yoshiike F, Agatsuma T, Yamamoto R, Ono Y,Suzuki T, Hachiya T, Gomi D, Tateishi K,Hanaoka M, Koizumi T:Clinical analysis of patients treated with afatinib for advanced non-small cell lung cancer: A Nagano Lung Cancer Research Group observational study.Respiratory Investigation.54(6):462–467,2016.
  16. Yanagisawa S,Matsushita T,Yasuo M,Machida R,Ishii W and Kadoya M:Usefulness of F-18 FDG PET/CT in a Case of Relapsing Polychondritis.Shinshu Med J64(6):349-355,2016.

日本文

  1. 花岡正幸:特集 肺高血圧症の病態と治療2016 Up to Date 呼吸器疾患に伴う肺高血圧症に対する治療戦略.呼吸と循環64(6):576-581,2016.医学書院
  2. 江田清一郎,藤本圭作,花岡正幸,久保惠嗣:長野県における在宅人工呼吸療法の現状.日本呼吸ケア・リハビリテーション学会誌,26(1):78-84,2016.
  3. 林田美江,安藤克利,関谷充晃,瀬山邦明,井上義一,巽 浩一郎:LAMを有する成人女性のおいてmTOR阻害薬は第一選択となりますか?.日本呼吸器学会誌,5(4):166-171,2016.
  4. 花岡正幸:高地肺水腫.日本病態生理学会雑誌,25(2):31,2016.
  5. 町田良亮:私がなぜ現在の科目を選んだか「呼吸器・感染症内科」.信州医誌,64(4):208,2016.
  6. 花岡正幸:特集呼吸器疾患:症例から病態生理学/分子病態学へ 肺高血圧症.呼吸と循環,64(10):985-990,2016.
  7. 山本洋,浅香志穂,植原剛,川上聡,浜野英明,川茂幸:特集 IgG4関連疾患:全身から肝胆膵の病態に迫る 知っておく多臓器病変と鑑別疾患 肺病変はどこまであきらかになったのか?.「肝胆膵」,73(4):567‐576,2016.
  8. 牛木淳人,花岡正幸:薬剤性肺障害の臨床像.呼吸器内科,30(4):330-335,2016.
  9. 花岡正幸:綜説 薬剤性肺障害.呼吸と循環,64(11):1108-1114,2016.
  10. 花岡正幸:巻頭言 深山リンドウを探して, 信州医誌64(6):327—328,2016.
  11. 加藤あかね,雲登卓瑪,小林信光,市山崇史,本田孝行,花岡正幸:電子顕微鏡による高地肺水腫の肺病理組織像の検討.登山医学Japanese Journal of Mountain Medicine,36:138-142,2016.
  12. 花岡正幸:COPD最新の話題 座談会 最新の病態解析方法や気管支内バルブによる治療の今後の課題を考える,COPD Selected Papers,7(1):pp13-19, メディカルレビュー社,東京,2016.
  13. 花岡正幸:Ⅴ高血圧症・肺高血圧 2.呼吸器疾患に伴うPHに対する治療戦略.Annual Review循環器2016,pp164-169, 中外医学社,東京,2016.
  14. 花岡正幸:Ⅵ呼吸器系疾患の診断・治療・ケア60.重症肺炎の治療指針.岡元和文(編著),救急・集中治療最新ガイドライン2016-2017, pp205-206, 総合医学社,東京,2016.
  15. 花岡正幸:肺動脈性肺高血圧症. 山口徹,北原光夫(監修), 福井次矢,高木誠,小室一成(総編集),今日の治療指針 私はこう治療している, pp366-367,医学書院,東京,2016.
  16. 花岡正幸:10 高地肺水腫. 杉山幸比呂,門田淳一,弦間昭彦(編集), 呼吸器疾患最新の治療2016-2018,pp179-181, 南江堂,東京,2016.
  17. 花岡正幸:「今日も山日和」第10座.雲の上の診療所:常念診療所, LiSA, 23
    11):1066-1067,メディカル・サイエンス・インターナショナル,東京,2016.
  18. 花岡正幸:座談会 呼吸器疾患合併肺動脈性肺高血圧症-病態に応じた的確な治療を目指して-.日経メディカルOnline抜刷(2016.8)

 

 

過去の業績を見る